158 related articles for article (PubMed ID: 29195127)
41. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
Sun R; Li AL; Wei HM; Tian ZG
Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-12 (IL-12) alone or in synergistic combination with IL-2 for in vitro activation of human bone marrow: differential effects at different time points.
Verma UN; Mazumder A
Bone Marrow Transplant; 1995 Sep; 16(3):365-72. PubMed ID: 8535308
[TBL] [Abstract][Full Text] [Related]
43. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.
Ewen EM; Pahl JHW; Miller M; Watzl C; Cerwenka A
Eur J Immunol; 2018 Feb; 48(2):355-365. PubMed ID: 29105756
[TBL] [Abstract][Full Text] [Related]
44. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
45. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
[TBL] [Abstract][Full Text] [Related]
47. The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo.
Ke M; Wang H; Zhang M; Tian Y; Wang Y; Li B; Yu J; Dou J; Xi T; Zhou C
Biochem Pharmacol; 2014 May; 89(1):119-30. PubMed ID: 24630931
[TBL] [Abstract][Full Text] [Related]
48. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
49. In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma.
Gandoglia I; Ivaldi F; Carrega P; Armentani E; Ferlazzo G; Mancardi G; Kerlero de Rosbo N; Uccelli A; Laroni A
Immunol Lett; 2017 Jan; 181():109-115. PubMed ID: 27919749
[TBL] [Abstract][Full Text] [Related]
50. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
[TBL] [Abstract][Full Text] [Related]
51. Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor.
Sahm C; Schönfeld K; Wels WS
Cancer Immunol Immunother; 2012 Sep; 61(9):1451-61. PubMed ID: 22310931
[TBL] [Abstract][Full Text] [Related]
52. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice.
Park HR; Ju EJ; Jo SK; Jung U; Kim SH; Yee ST
BMC Cancer; 2009 Mar; 9():85. PubMed ID: 19292900
[TBL] [Abstract][Full Text] [Related]
53. Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function.
Degos C; Heinemann M; Barrou J; Boucherit N; Lambaudie E; Savina A; Gorvel L; Olive D
Front Immunol; 2019; 10():877. PubMed ID: 31105699
[TBL] [Abstract][Full Text] [Related]
54. Cisplatin-based polychemotherapy reduces the natural cytotoxicity of peripheral blood mononuclear cells in patients with advanced ovarian carcinoma and their in vitro responsiveness to interleukin-12 incubation.
Garzetti GG; Ciavattini A; Muzzioli M; Romanini C
Cancer; 1999 May; 85(10):2226-31. PubMed ID: 10326702
[TBL] [Abstract][Full Text] [Related]
55. IL-10 Enhances Human Natural Killer Cell Effector Functions via Metabolic Reprogramming Regulated by mTORC1 Signaling.
Wang Z; Guan D; Huo J; Biswas SK; Huang Y; Yang Y; Xu S; Lam KP
Front Immunol; 2021; 12():619195. PubMed ID: 33708210
[TBL] [Abstract][Full Text] [Related]
56. Frontline Science: IL-18 primes murine NK cells for proliferation by promoting protein synthesis, survival, and autophagy.
El-Darawish Y; Li W; Yamanishi K; Pencheva M; Oka N; Yamanishi H; Matsuyama T; Tanaka Y; Minato N; Okamura H
J Leukoc Biol; 2018 Aug; 104(2):253-264. PubMed ID: 29603367
[TBL] [Abstract][Full Text] [Related]
57. IFN-β activates cytotoxic function of human natural killer cells toward IL-27 and poly(I:C) stimulated PC3 and DU145 cells.
Kourko O; Hawke LG; Ormiston ML; Gee K
Cell Immunol; 2023 May; 387():104718. PubMed ID: 37068442
[TBL] [Abstract][Full Text] [Related]
58. Artesunate-induced ATG5-related autophagy enhances the cytotoxicity of NK92 cells on endometrial cancer cells via interactions between CD155 and CD226/TIGIT.
Zhang J; Zhou L; Xiang JD; Jin CS; Li MQ; He YY
Int Immunopharmacol; 2021 Aug; 97():107705. PubMed ID: 33933849
[TBL] [Abstract][Full Text] [Related]
59. Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment.
Ruiz-García R; Vargas-Hernández A; Chinn IK; Angelo LS; Cao TN; Coban-Akdemir Z; Jhangiani SN; Meng Q; Forbes LR; Muzny DM; Allende LM; Ehlayel MS; Gibbs RA; Lupski JR; Uzel G; Orange JS; Mace EM
J Allergy Clin Immunol; 2018 Aug; 142(2):605-617.e7. PubMed ID: 29330011
[TBL] [Abstract][Full Text] [Related]
60. Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects.
Wang Z; Yang Z; Qu C; Li J; Wang X
Int Urol Nephrol; 2023 Aug; 55(8):1957-1970. PubMed ID: 37253929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]